SCHEMBL10157726

SCHEMBL10157726

NN1Cc2ccc(O)cc2C1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.47
ESR2 Q92731 7/20 0.43
ESR1 P03372 6/20 0.43
ABHD6 Q9BV23 1/20 0.42
DRD2 P14416 2/20 0.42
DRD3 P35462 2/20 0.42
DRD1 P21728 2/20 0.42
DRD5 P21918 2/20 0.42
OPRK1 P41145 1/20 0.41
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8485819 0.77 DRD1 (0.57) PDK2ESR2ESR1ABHD6DRD2
SCHEMBL10269052 0.77 PDK2 (0.47) PDK2ESR2ESR1ABHD6DRD2
SCHEMBL11434101 0.77 HTR2A (0.42)
SCHEMBL14067241 0.76 PDK2 (0.46) PDK2ESR2ESR1ABHD6DRD2
SCHEMBL30142515 0.75 ABHD6 (0.53) PDK2ESR2ESR1ABHD6HSP90AA1
SCHEMBL14223471 0.74 PDK2 (0.42) PDK2MEN1KMT2A
SCHEMBL5517884 0.74 MEN1 (0.70) PDK2ESR2ESR1ABHD6DRD2
SCHEMBL19675161 0.73 DPP9 (0.47)
SCHEMBL14626144 0.72 PDK2 (0.47) PDK2ESR2ESR1ABHD6DRD2
SCHEMBL11270263 0.72 DRD2 (0.44) PDK2ESR2ESR1ABHD6DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788333-B1 1,2,4-TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INT (DE) 2016-03-23 EP disclosed
WO-2013083741-A1 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 WO disclosed
WO-2012052390-A1 N-2-(2-PYRIDINYL)-4-PYRIMIDINYL-BETA-ALANINE DERIVATIVES AS INHIBITORS OF HISTONE DEMETHYLASE JMJD3 GLAXO GROUP LIMITED (GB) 2012-04-26 WO disclosed
WO-2008044054-A2 HYDROXY-SUBSTITUTED BENZOIC ACID AMIDE COMPOUNDS FOR USE IN THERAPY ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed